Differentiating Behaviors: Proactive, Ethical, Consistent, Enthusiastic, Collaborative, Competitive, Dependable

Business Functions: Institutional and Physician Sales, Channel Account Contracting and Pricing/Reimbursement,
New Product Launch, Marketing Campaign Development, Data Management, Professional Training/Development
Disease State experience: Injectable Biotech therapies (IV, subcutaneous), Oral Therapies (PO)
Cardiology, Hematology, Oncology, Endocrinology, Neuroscience, Pulmonology, Respiratory, Immunology,
Gastroenterology
Professional Objective: To advance my career in the biopharmaceutical industry as a specialty sales manager and use my
skills, and experience to achieve specified goals.
Amit Garg
sevaramyoga@comcast.net
Jupiter, FL 33458 Cell: (305) 775-2285
Novo Nordisk Pharmaceuticals, Inc. 1/03 -6/14
Senior Biopharmaceuticals Sales Manager
Central and south Florida (Tampa/Orlando/West Palm Beach/Ft Lauderdale/Miami/Naples)

Promote usage of Coagulation Factor VIIa Recombinant (NovoSeven), and somatropin (DNA origin) injection,
(Norditropin) as indicated by FDA label.
Targets: Hematology/oncology specialty physicians with subset of Cardiology centers, Endocrinologists, specialty treatment
centers, contracting/distribution and reimbursement channels
Q1 2014 Ranked #3 in Nation 120% of $6,132,000
2013 Ranked #1 in Nation, 150% of $12,373,000
2011, 2013 Achieved ratings of OUTSTANDING
2009, 2010, 2012 Achieved ratings of EXCEEDS
2008 Achieved 112% of NovoSeven of $12,466,002
2007 Achieved 84% of NovoSeven of $13,527,363
**patient representing $8.4 million passed away April 2006

Direct Sales responsibilities and accolades:
Educating hematologists/oncologists and teaching institutions / sharing clinical usage research of NovoSeven.
Disseminating Medical information to Cardiologists regarding EB during heart surgeries/catheterizations.
Educating endocrinologists and teaching institutions/ sharing clinic usage research of Norditropin.
Chosen to be member of Sales and Marketing Council (marketing rotation) for 2 years
Regionally lead CLOT team (national group working with senior leadership and marketing to discuss outcome based selling)
Lead nation in percentage of call reach and frequency for 2 years, 2006, 2007
Educating and assisting regional endocrinology societies in regards to Norditropin
Contracting experience 2003-Present:
Met, presented, and negotiated purchasing contracts to Florida specific hospitals, specialty pharmacies, and home
health care accounts.
Negotiated and presented reimbursement schedules consistent with Florida Medicare and Medicaid contracts to
Florida based distribution channels
Coordinated with headquarters/marketing function to create pricing strategy for Novoseven and Norditropin
Responsibilities encompassed monitoring compliance with existing contracts within legal framework
Participated in Medicare/Medicaid meetings supporting National Hemophilia Foundation efforts around granting equal
access for patients to coagulation factors (presented cost benefit analysis when treating hemophilia).

Targeted accounts within Florida Territory include:
Humana, Vista, Tenent, Aetna, Blue Cross Blue Shield of Florida, Florida Blood services
Curascript, Cardinal Specialty, Biocare, BDI, Prodigy
Walgreens/OptionCare
Caremark, Accredo/HHS
HOSS, Matrix Health Systems, Factor Foundation of America
Baptist Health system, Tenet Health system, Naples Health system
Broward Hospital System(Chris Evert Cancer Center), Memorial Hospital System(Joe Dimaggio Cancer Center)
University of Miami (Jackson Medical, Sylvester Cancer Center), Miami Childrens Cancer Center

2006: 70% of NovoSeven of $18,905,803
2005: 101% of NovoSeven 126% of Norditropin
2004: 115% of NovoSeven 142% of Norditropin
2003: 103% of NovoSeven 111% of Norditropin



Amit Garg Cell (305) 775-2285
Achieved 120% of Zyprexa quota, Q1 2002
Achieved 120% of Prozac quota and 134% of Zyprexa quota, Jan - Dec 2001
Achieved 112% of Prozac quota and 132% of Zyprexa quota, May- Dec 2000
Achieved 105% of 2000 annual total dollar quota ($3.242 achieved vs. $3.077 million)
AstraZeneca (formerly Astra Merck) 5/97 4/00
Pharmaceutical Specialist
Manage physician base and hospitals in Hollywood, Pembroke Pines, S. Ft. Lauderdale
(cardiologists, gastroenterologists, pulmonologists, allergists, immunologists, primary care).
Set up learning programs for Nova Southeastern College (residents)
Maintain expenditure rates for budget through hosting physician programs
Partner with P&G and PDI for full potential of market share increase
Use PCL to maintain target and routing criteria and reflect minimum 70% allocation of samples
Physician based learning programs, teleconferences, luncheons
Achieved 101% of Prilosec quota, 101% of Plendil quota Jan Jun 1999
Achieved 144% of RBOs, Jan Dec 1998
Achieved 105% of Prilosec quota, 101% Plendil, 121% Atacand, Jan Dec 1998
Abbott Laboratories, ROSS Products Division 5/96 2/97
Retail Sales Representative
Managed consumer products at retail level within south Florida territory.
Products included:
Ensure product line for adult nutritionals
Similac, Isomil, Pediasure, Pedialyte, Toddlers Best for pediatric nutritionals
Clear Eyes, CLR, Murine, Selsun Blue
Practice category management at retail level

EDUCATION
Eli Lilly and Company 4/01-4/02
Training and Development Associate
Onboarded new representatives for antipsychotic market
Developed disease state training materials
Administered coaching/role play scenarios
Evaluated and tested representatives to qualify for field ready experience

Neuroscience Hospital Specialist 5/00 4/02
Call on institutions in South Florida area and focus on psychiatrists for antipsychotic and antidepressant market, specifically
Veterans Administration Hospitals and Florida State Hospital. Activities include:
Prozac team leader, Bipolar team leader
Earned Three awards for Peer leadership and teamwork honor, January 2002, June 2001, May 2000
Pfizer (formerly Genetics Institute, Wyeth) 4/02 1/03
Hemophilia Specialty Manager
Responsible for increase in utilization of Factor VIII Recombinant (Refacto)
Responsible for increase in utilization of Factor IX Recombinant (Benefix) products in Florida
Promoting products to hospitals via pharmacy directors, coagulation lab directors, social workers, case managers
Initiating and promoting programs with the National Hemophilia Foundation and Hemophilia Foundation of Greater Florida
Partnering with home health care and hematologists to identify patients for upgrading to recombinant products
Achieved 147% of Benefix quota, Q4 2002
Achieved 162% of Benefix quota, Q3 2002
Achieved 130% of Benefix quota, Q2 2002
MBA, Management, Marketing and MIS conferred July 1995, University of South Florida, Tampa, Florida
Bachelor of Arts in biology / psychology conferred May 1991 Rutgers College, Rutgers University, New Jersey

References upon request